Planet 13 Holdings (PLNH) Receivables (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Receivables of $2.3 million for Q1 2026, up 40.2% year-over-year from $1.6 million in Q1 2025, and down 51.89% quarter-over-quarter from $4.8 million in Q4 2025.
Planet 13 Holdings (PLNH) Receivables (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Receivables for 6 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables rose 40.2% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 40.2% YoY), while the FY2025 annual figure was $4.8 million, up 223.28% from the prior year.
- Receivables fell to $2.3 million in Q1 2026 per PLNH's latest filing, from $4.8 million in the prior quarter.
- Across five years, Receivables topped out at $4.8 million in Q4 2025 and bottomed at $1.0 million in Q1 2024.
- Historically, Receivables has averaged $1.6 million across 5 years, with a median of $1.3 million in 2022.
- Annual changes were most pronounced in 2023 — Receivables plunged 40.27% — and 2025, when it jumped 223.28%.
- Planet 13 Holdings' Receivables stood at $1.3 million in 2022, then decreased by 9.86% to $1.2 million in 2023, then rose by 23.18% to $1.5 million in 2024, then surged by 223.28% to $4.8 million in 2025, then tumbled by 51.89% to $2.3 million in 2026.
- Business Quant data shows PLNH's Receivables at $2.3 million in Q1 2026, $4.8 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | 4.76 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.63 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 1.54 Mn |
| Mar 31, 2022 | 2.05 Mn |
| Dec 31, 2021 | 1.22 Mn |